Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 0 | 0 | 0 | 65 |
| Gross Profit | N/A | N/A | N/A | N/A | 65 |
| Operating Expenses | 21,950 | 17,477 | 21,211 | 23,085 | 25,116 |
| Operating Income | -21,950 | -17,477 | -21,211 | -23,085 | -25,051 |
| Other Income | 2,267 | 21,242 | -24,286 | -435 | 5,356 |
| Pre-tax Income | -19,683 | 3,765 | -45,497 | -23,519 | -19,695 |
| Net Income Continuous | -19,683 | 3,765 | -45,497 | -23,519 | -19,695 |
| Net Income | $-19,683 | $3,765 | $-45,497 | $-23,519 | $-19,695 |
| EPS Basic Total Ops | -0.28 | 0.18 | -0.87 | -0.61 | -0.51 |
| EPS Basic Continuous Ops | -0.28 | 0.18 | -0.87 | -0.61 | -0.51 |
| EPS Diluted Total Ops | -0.28 | 0.18 | -0.87 | -0.61 | -0.51 |
| EPS Diluted Continuous Ops | -0.28 | 0.18 | -0.87 | -0.61 | -0.51 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.31 | -0.44 | -0.61 | -0.51 |
| EBITDA(a) | $-21,215 | $-16,776 | $-20,397 | $-22,356 | $-24,308 |